🇺🇸 FDA

Intelligence · Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe — grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≤24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months — use filters for patent-cliff planning.

Page 4 of 78

  1. US 12012438

    Brachyury deletion mutants, non-yeast vectors encoding brachyury deletion mutants, and their use

    Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12012455

    Human monoclonal antibodies specific for FLT3 and uses thereof

    Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12012463

    High affinity monoclonal antibodies targeting glypican-2 and uses thereof

    Expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12005115

    Epstein-barr virus vaccines

    Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11998520

    Methods for decreasing injuries associated with intraoperative hypotension

    Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11999796

    Anti-CD70 chimeric antigen receptors

    Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11999720

    Pyrazolylacylpyrazoline compounds and method for treating pain

    Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11999747

    Furoquinolinediones as inhibitors of TDP2

    Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11992523

    Method for producing chikungunya virus (CHIKV) virus-like particles comprising the C, E2, and E1 structural proteins

    Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11993640

    Treating inflammatory lung disease

    Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11992519

    Chimeric antigen receptor (CAR) that targets chemokine receptor CCR4 and its use

    Expires Mon May 23 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11986534

    Treatment of anthrax with pegylated capsule-degrading enzyme

    Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11981750

    Antigenic tripeptides derived from Mycobacterium avium subsp. paratuberculosis s-type strains, derivatives and uses thereof

    Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11981707

    Prefusion RSV F proteins and their use

    Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11980637

    Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy

    Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11980698

    Muscle cell patches and uses therefor

    Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11980640

    Bicistronic chimeric antigen receptors and their uses

    Expires Mon May 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11976299

    Methods of preparing an isolated population of dendritic cells and methods of treating cancer using same

    Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11975063

    Recombinant chimeric bovine/human parainfluenza virus 3 expressing rsv g and its use

    Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11976109

    Neutralizing antibodies to ebola virus glycoprotein and their use

    Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11969466

    Stabilized influenza hemagglutinin stem region trimers and uses thereof

    Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11964010

    Prefusion coronavirus spike proteins and their use

    Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11963959

    Inhibitors for coronavirus

    Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11964944

    Compounds and methods for treating, detecting, and identifying compounds to treat apicomplexan parasitic diseases

    Expires Mon Apr 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11959096

    Methods for selective inhibition of pluripotent stem cells

    Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11951136

    Preservation of pancreatic islet grafts in the extrahepatic space

    Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11951131

    Anti-SLAMF7 chimeric antigen receptors

    Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11951152

    Microparticle compositions for controlled delivery of telmisartan and actinomycin D

    Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11951159

    Cattle fever tick-infestation vaccines and uses thereof

    Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11945781

    Compounds for the treatment of acute and chronic kidney disease

    Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11945855

    Recombinant polypeptides comprising modified MHC class II DRa1 domains and methods of use

    Expires Mon Mar 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11938221

    Multivalent nanoparticle-based vaccines

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11939301

    5HT1F receptor agonists and mitochondrial biogenesis

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11939377

    Affinity matured CD22-specific monoclonal antibody and uses thereof

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11939345

    Physiologically stable fluorophore and performing fluorescence probing

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11939365

    T cell receptors recognizing mutated P53

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 11939356

    Self-assembling insect ferritin nanoparticles

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 11939297

    Cannabinoid receptor mediating compounds

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 11938177

    Peptide vaccine formulations and use thereof for inducing an immune response

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 11932617

    Compound for use in retinal diseases

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 11925611

    Use of ZT-1A and analogs thereof to prevent and/or treat neurodegenerative and neurocognitive disorders

    Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 11926656

    Antibodies and methods for the diagnosis and treatment of Epstein Barr Virus infection

    Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 11925664

    Intracellular genomic transplant and methods of therapy

    Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 11918638

    Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts

    Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 11918640

    Methods of preparing anti-human papillomavirus antigen T cells

    Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 11919896

    [1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor and use thereof

    Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 11918639

    Methods and compositions for inducing protective immunity against filovirus infection

    Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 11911481

    Compositions and methods for treating RSV-infections

    Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.